Carvedilol-induced antagonism of angiotensin II: A matter of α1-adrenoceptor blockade

Wendy W. Batenburg, Joep H M Van Esch, Ingrid M. Garrelds, Ulrich P. Jorde, Jos M J Lamers, Dick H W Dekkers, Thomas Walther, Elaine Kellett, Graeme Milligan, Jorge P. Van Kats, A. H Jan Danser

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

OBJECTIVE: To investigate whether renin-angiotensin system blockade might underlie the favorable metabolic effects of the nonselective β + α1-adrenoceptor blocker carvedilol as compared with the selective β1-adrenoceptor blocker metoprolol. METHODS: Human coronary microarteries (HCMAs), obtained from 32 heart valve donors, were mounted in myographs. RESULTS: Angiotensin II and the α1-adrenoceptor agonist phenylephrine constricted HCMAs to maximally 63 ± 10 and 46 ± 15% of the contraction to 100 mmol/l K. Neither carvedilol, metoprolol, the nonselective β-adrenoceptor antagonist propranolol, nor the α1-adrenoceptor antagonist prazosin affected the constrictor response to angiotensin II. α1-adrenoreceptors and β-adrenoceptors are thus not involved in the direct constrictor effects of angiotensin II. When added to the organ bath at a subthreshold concentration, angiotensin II greatly amplified the response to phenylephrine. Both carvedilol and the angiotensin II type 1 (AT1) receptor antagonist irbesartan inhibited this angiotensin II-induced potentiation. Furthermore, carvedilol blocked the angiotensin II-induced amplification of phenylephrine-induced inositol phosphate accumulation in cardiomyocytes. CONCLUSIONS: AT1-α1-receptor crosstalk, involving inositol phosphates, sensitizes HCMAs to α1-adrenoceptor agonists. Our results suggest that, in the presence of an increased sympathetic tone, carvedilol provides AT1 receptor blockade via its α1-adrenoceptor blocking effects. This could explain the favorable effects of carvedilol versus metoprolol.

Original languageEnglish (US)
Pages (from-to)1355-1363
Number of pages9
JournalJournal of Hypertension
Volume24
Issue number7
DOIs
StatePublished - Jun 2006
Externally publishedYes

Fingerprint

Angiotensin II
Adrenergic Receptors
Metoprolol
Phenylephrine
Inositol Phosphates
irbesartan
Angiotensin II Type 1 Receptor Blockers
Angiotensin Type 1 Receptor
carvedilol
Prazosin
Heart Valves
Renin-Angiotensin System
Baths
Cardiac Myocytes
Propranolol

Keywords

  • Adrenergic receptors
  • Angiotensin
  • Heart failure
  • Signal transduction

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology

Cite this

Batenburg, W. W., Van Esch, J. H. M., Garrelds, I. M., Jorde, U. P., Lamers, J. M. J., Dekkers, D. H. W., ... Danser, A. H. J. (2006). Carvedilol-induced antagonism of angiotensin II: A matter of α1-adrenoceptor blockade. Journal of Hypertension, 24(7), 1355-1363. https://doi.org/10.1097/01.hjh.0000234116.17778.63

Carvedilol-induced antagonism of angiotensin II : A matter of α1-adrenoceptor blockade. / Batenburg, Wendy W.; Van Esch, Joep H M; Garrelds, Ingrid M.; Jorde, Ulrich P.; Lamers, Jos M J; Dekkers, Dick H W; Walther, Thomas; Kellett, Elaine; Milligan, Graeme; Van Kats, Jorge P.; Danser, A. H Jan.

In: Journal of Hypertension, Vol. 24, No. 7, 06.2006, p. 1355-1363.

Research output: Contribution to journalArticle

Batenburg, WW, Van Esch, JHM, Garrelds, IM, Jorde, UP, Lamers, JMJ, Dekkers, DHW, Walther, T, Kellett, E, Milligan, G, Van Kats, JP & Danser, AHJ 2006, 'Carvedilol-induced antagonism of angiotensin II: A matter of α1-adrenoceptor blockade', Journal of Hypertension, vol. 24, no. 7, pp. 1355-1363. https://doi.org/10.1097/01.hjh.0000234116.17778.63
Batenburg, Wendy W. ; Van Esch, Joep H M ; Garrelds, Ingrid M. ; Jorde, Ulrich P. ; Lamers, Jos M J ; Dekkers, Dick H W ; Walther, Thomas ; Kellett, Elaine ; Milligan, Graeme ; Van Kats, Jorge P. ; Danser, A. H Jan. / Carvedilol-induced antagonism of angiotensin II : A matter of α1-adrenoceptor blockade. In: Journal of Hypertension. 2006 ; Vol. 24, No. 7. pp. 1355-1363.
@article{5927f01d7fcc4bd6a0c3cae84df52be3,
title = "Carvedilol-induced antagonism of angiotensin II: A matter of α1-adrenoceptor blockade",
abstract = "OBJECTIVE: To investigate whether renin-angiotensin system blockade might underlie the favorable metabolic effects of the nonselective β + α1-adrenoceptor blocker carvedilol as compared with the selective β1-adrenoceptor blocker metoprolol. METHODS: Human coronary microarteries (HCMAs), obtained from 32 heart valve donors, were mounted in myographs. RESULTS: Angiotensin II and the α1-adrenoceptor agonist phenylephrine constricted HCMAs to maximally 63 ± 10 and 46 ± 15{\%} of the contraction to 100 mmol/l K. Neither carvedilol, metoprolol, the nonselective β-adrenoceptor antagonist propranolol, nor the α1-adrenoceptor antagonist prazosin affected the constrictor response to angiotensin II. α1-adrenoreceptors and β-adrenoceptors are thus not involved in the direct constrictor effects of angiotensin II. When added to the organ bath at a subthreshold concentration, angiotensin II greatly amplified the response to phenylephrine. Both carvedilol and the angiotensin II type 1 (AT1) receptor antagonist irbesartan inhibited this angiotensin II-induced potentiation. Furthermore, carvedilol blocked the angiotensin II-induced amplification of phenylephrine-induced inositol phosphate accumulation in cardiomyocytes. CONCLUSIONS: AT1-α1-receptor crosstalk, involving inositol phosphates, sensitizes HCMAs to α1-adrenoceptor agonists. Our results suggest that, in the presence of an increased sympathetic tone, carvedilol provides AT1 receptor blockade via its α1-adrenoceptor blocking effects. This could explain the favorable effects of carvedilol versus metoprolol.",
keywords = "Adrenergic receptors, Angiotensin, Heart failure, Signal transduction",
author = "Batenburg, {Wendy W.} and {Van Esch}, {Joep H M} and Garrelds, {Ingrid M.} and Jorde, {Ulrich P.} and Lamers, {Jos M J} and Dekkers, {Dick H W} and Thomas Walther and Elaine Kellett and Graeme Milligan and {Van Kats}, {Jorge P.} and Danser, {A. H Jan}",
year = "2006",
month = "6",
doi = "10.1097/01.hjh.0000234116.17778.63",
language = "English (US)",
volume = "24",
pages = "1355--1363",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Carvedilol-induced antagonism of angiotensin II

T2 - A matter of α1-adrenoceptor blockade

AU - Batenburg, Wendy W.

AU - Van Esch, Joep H M

AU - Garrelds, Ingrid M.

AU - Jorde, Ulrich P.

AU - Lamers, Jos M J

AU - Dekkers, Dick H W

AU - Walther, Thomas

AU - Kellett, Elaine

AU - Milligan, Graeme

AU - Van Kats, Jorge P.

AU - Danser, A. H Jan

PY - 2006/6

Y1 - 2006/6

N2 - OBJECTIVE: To investigate whether renin-angiotensin system blockade might underlie the favorable metabolic effects of the nonselective β + α1-adrenoceptor blocker carvedilol as compared with the selective β1-adrenoceptor blocker metoprolol. METHODS: Human coronary microarteries (HCMAs), obtained from 32 heart valve donors, were mounted in myographs. RESULTS: Angiotensin II and the α1-adrenoceptor agonist phenylephrine constricted HCMAs to maximally 63 ± 10 and 46 ± 15% of the contraction to 100 mmol/l K. Neither carvedilol, metoprolol, the nonselective β-adrenoceptor antagonist propranolol, nor the α1-adrenoceptor antagonist prazosin affected the constrictor response to angiotensin II. α1-adrenoreceptors and β-adrenoceptors are thus not involved in the direct constrictor effects of angiotensin II. When added to the organ bath at a subthreshold concentration, angiotensin II greatly amplified the response to phenylephrine. Both carvedilol and the angiotensin II type 1 (AT1) receptor antagonist irbesartan inhibited this angiotensin II-induced potentiation. Furthermore, carvedilol blocked the angiotensin II-induced amplification of phenylephrine-induced inositol phosphate accumulation in cardiomyocytes. CONCLUSIONS: AT1-α1-receptor crosstalk, involving inositol phosphates, sensitizes HCMAs to α1-adrenoceptor agonists. Our results suggest that, in the presence of an increased sympathetic tone, carvedilol provides AT1 receptor blockade via its α1-adrenoceptor blocking effects. This could explain the favorable effects of carvedilol versus metoprolol.

AB - OBJECTIVE: To investigate whether renin-angiotensin system blockade might underlie the favorable metabolic effects of the nonselective β + α1-adrenoceptor blocker carvedilol as compared with the selective β1-adrenoceptor blocker metoprolol. METHODS: Human coronary microarteries (HCMAs), obtained from 32 heart valve donors, were mounted in myographs. RESULTS: Angiotensin II and the α1-adrenoceptor agonist phenylephrine constricted HCMAs to maximally 63 ± 10 and 46 ± 15% of the contraction to 100 mmol/l K. Neither carvedilol, metoprolol, the nonselective β-adrenoceptor antagonist propranolol, nor the α1-adrenoceptor antagonist prazosin affected the constrictor response to angiotensin II. α1-adrenoreceptors and β-adrenoceptors are thus not involved in the direct constrictor effects of angiotensin II. When added to the organ bath at a subthreshold concentration, angiotensin II greatly amplified the response to phenylephrine. Both carvedilol and the angiotensin II type 1 (AT1) receptor antagonist irbesartan inhibited this angiotensin II-induced potentiation. Furthermore, carvedilol blocked the angiotensin II-induced amplification of phenylephrine-induced inositol phosphate accumulation in cardiomyocytes. CONCLUSIONS: AT1-α1-receptor crosstalk, involving inositol phosphates, sensitizes HCMAs to α1-adrenoceptor agonists. Our results suggest that, in the presence of an increased sympathetic tone, carvedilol provides AT1 receptor blockade via its α1-adrenoceptor blocking effects. This could explain the favorable effects of carvedilol versus metoprolol.

KW - Adrenergic receptors

KW - Angiotensin

KW - Heart failure

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=33745462980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745462980&partnerID=8YFLogxK

U2 - 10.1097/01.hjh.0000234116.17778.63

DO - 10.1097/01.hjh.0000234116.17778.63

M3 - Article

C2 - 16794485

AN - SCOPUS:33745462980

VL - 24

SP - 1355

EP - 1363

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 7

ER -